SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-19-000557
Filing Date
2019-06-27
Accepted
2019-06-27 16:21:23
Documents
1
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT onconova_fm4jun252019.html 4  
1 OWNERSHIP DOCUMENT onconova_fm4jun252019.xml 4 3765
  Complete submission text file 0000905718-19-000557.txt   5539
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-446-2466
TYNDALL CAPITAL PARTNERS L P (Reporting) CIK: 0001219314 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 19925553